Brind.

BioNTech and Bristol Myers Squibb announced a partnership to advance oncology treatment and received EMA authorization for a vaccine.

1 report, 1 independent Updated Aug 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Bristol-Myers Squibb BioNTech

Keep exploring

The entities involved

Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
- FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
BioNTech
Biotechnology company from Germany

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 5Simply Wall St.BioNTech (BNTX) Reports Increased Sales And Reduced Losses In Q2 2025 BioNTech recently reported significant improvements in its financial performance, with quarterly sales nearly doubling compared t